您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > MSC-4106
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
MSC-4106
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
MSC-4106图片
CAS NO:2738542-58-8
包装与价格:
包装价格(元)
1 mg电议
5 mg电议
10 mg电议
25 mg电议
50 mg电议
100 mg电议
1 mL*10 mM(in DMSO)电议

产品介绍
MSC-4106 是一种有效的、具有口服活性的 YAP/TAZ-TEAD 抑制剂。 MSC-4106 阻断 TEAD1 和 TEAD3 的自棕榈酰化,并且对 NCI-H226 异种移植瘤模型显示抑制作用。

产品描述

MSC-4106 is an orally active and potent inhibitor of YAP/TAZ-TEAD. MSC-4106 inhibits TEAD1 or TEAD3 auto-palmitoylation and exhibits inhibitory effect on NCI-H226 tumor xenograft model [1].

体外活性

MSC-4106 (10 μM, 24 h) inhibited SK-HEP-1 reporter and NCI-266 cell viability with IC 50 values of 4 nM and 14 nM, respectively [1]. MSC-4106 (10 μM, 6 h) crystallizes in the P-site of TEAD1, and against TEAD1 or TEAD3 palmitoylation in TEAD-Overexpressing HEK293 Cells by 97.3% and 75.9%, respectively [1]. MSC-4106 (10 μM, 4 d) targets TEAD suggested by a reduction in viability of NCI-H226 cells [1]. Cell Viability Assay [1] Cell Line: NCI-H226 (YAP dependent); SW620 YAP/TAZ KO (Yap-independent) cells Concentration: 0, 3, 6, 9, 12, 15, 18, 21, 24, 26, 30 μM Incubation Time: 96 hours Result: Showed inhibitory effect to NCI-H226 and general cytotoxic to SW620 (IC 50 >30 μM). Immunofluorescence [1] Cell Line: SK-HEP-1 Concentration: 0, 3, 6, 9, 12, 15, 18, 21, 24, 26, 30 μM Incubation Time: 24 hours Result: Inhibited YAP-TEAD interation.

体内活性

MSC-4106 (P.O.; 100 mg/kg once daily; 7 days) shows anti-tumor effect with controlled tumor volume and good tolerability with stable body weight in mice [1]. MSC-4106 (P.O.; 1, 5, 100 mg/kg once daily; 6, 24, 30, 48, and 72 h) down-regulates Cyr61 (cysteine-rich angiogenic inducer 61) expression, the TEAD-regulated target gene, in tumor lysates at all time points at 100 mg/kg and 24 h at 5 mg/kg [1]. Pharmacokinetics (PK) profile in different species [1] Parameter Mouse Rat Dog Cl (l/h/kg) 0.2 0.7 0.05 PO t 1/2 (h) 45 40 3.6 PO AUC (μg h/mL) 45 10 33 V ss (L/kg) 2 5 0.3 F (%) >90 80 18 Note : PO studies were performed at 10 mg/kg; MSC-4106 was formulated in 20% Kleptose in 50 mM PBS at pH 7.4. Animal Model: NCI-H226 xenograft model in H2d Rag2 female mice (9-week-old) [1] Dosage: 5, 100 mg/kg Administration: Oral gavage; once daily; 32 days Result: Resulted tumor growth controlled with 5 mg/kg while regressed with 100 mg/kg dosing after 32 treatment days.

Cas No.

2738542-58-8

分子式

C18H12F3N3O2

分子量

359.3

储存和溶解度

DMSO:225mg/mL (626.2mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years